Clinical Trial Update: Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer [NA]

View source ↗

Summary

The document reports an update on a neoadjuvant FOLFIRINOX trial for non-metastatic pancreatic cancer, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin calcium (calcium folinate)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Baylor Research Institute | Conditions: Pancreas Cancer, Localized Pancreas Cancer | NA | Status: UNKNOWN